Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1036 of 1,261

  1. US 7521054

    Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  2. US 7521063

    Multiple CPG oligodeoxynucleotides and their use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  3. US 7521175

    Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

    The Regents of the University of California · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  4. US 7521211

    IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  5. US 7521414

    Polyol macrolide antitumor-antibiotics from the marine actinomycete strain CNQ140

    The Regents of the University of California · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  6. US 7521192

    EDG: modulators of lymphocyte activation and migration

    Rigel Pharmaceuticals, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  7. US 7521479

    Methods of treating prion disease in mammals

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  8. US 7521421

    Deuterated cyclosporine analogs and methods of making the same

    Isotechnika, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  9. US 7521535

    Anti-microbial defensin-related peptides and methods of use

    The Board of Regents for Oklahoma State University · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  10. US 7521475

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  11. US 7521551

    Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy

    Miravant Pharmaceuticals, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  12. EP 2046782

    IMIDAZOLYLPYRIMIDINDERIVATE ZUR BEHANDLUNG VON MIT GLYKOGENSYNTHASEKINASE (GSK3) IN ZUSAMMENHANG STEHENDEN KRANKHEITEN

    ASTRAZENECA AB [SE] · Granted Apr 15, 2009 · Expires Apr 10, 2029

    granted

  13. US 7517971

    Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity

    The Regents of the University of Colorado · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  14. US 7517858

    Prodrugs of pharmaceuticals with improved bioavailability

    The Regents of the University of California · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  15. US 7517661

    Methods of screening for ligands for FPRL2

    Takeda Pharmaceutical Company Limited · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  16. US 7517531

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  17. US 7517871

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    ACADIA Pharmaceuticals Inc. · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  18. US 7517987

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  19. US 7517527

    Immunotoxin with in vivo T cell suppressant activity and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  20. US 7517886

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  21. US 7517865

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  22. US 7517849

    Inhibition of ABC transporters by transmembrane domain analogs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  23. US 7517910

    Alkoxyphenylpropanoic acid derivatives

    Takeda Pharmaceutical Company Limited · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  24. US 7517895

    Synthetic diazonamides

    The Board of Regents of the University of Texas System · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.